Cevimeline and Vomiting - a phase IV clinical study of FDA data

Summary:

Vomiting is reported as a side effect among people who take Cevimeline (cevimeline hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Vomiting when taking Cevimeline. It is created by eHealthMe based on reports of 1,450 people who have side effects when taking Cevimeline from the FDA, and is updated regularly.

What is Cevimeline?

Cevimeline has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,480 Cevimeline users. Check the latest studies of Cevimeline.

What is Vomiting?

Vomiting is found to be associated with 3,790 drugs and 5,750 conditions by eHealthMe. Check the latest studies of Vomiting.

On Apr, 19, 2026

1,450 people reported to have side effects when taking Cevimeline.
Among them, 60 people (4.14%) have Vomiting.

Among these 60 people:

How long have people been on Cevimeline when they have Vomiting? *

What is the gender of people who have Vomiting when taking Cevimeline? *

female: 91.23 %
male: 8.77 %

What is the age of people who have Vomiting when taking Cevimeline? *

What are other drugs people take besides Cevimeline? *

What are other side effects people have besides Vomiting? *

Nausea (feeling of having an urge to vomit): 41 people, 68.33%
Headache (pain in head): 22 people, 36.67%
Diarrhea: 22 people, 36.67%
Fatigue (feeling of tiredness): 20 people, 33.33%
Malaise (a feeling of general discomfort or uneasiness): 15 people, 25.00%
Joint Pain: 13 people, 21.67%
Hair Loss: 12 people, 20.00%
Dizziness: 12 people, 20.00%
Gait Disturbance: 11 people, 18.33%
Pain: 11 people, 18.33%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 11.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 11.67%
Pain: 6 people, 10.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 6.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 6.67%
Weight Loss: 3 people, 5.00%
Pain In Extremity: 3 people, 5.00%
Insomnia (sleeplessness): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cevimeline and have Vomiting?

- Check whether Vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cevimeline:

Cevimeline (1,480 reports)

Vomiting treatments and more:

Vomiting (529,395 reports)

Browse all side effects of Cevimeline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vomiting:

Vomiting (3,790 drugs)

Browse all the conditions that are associated with Vomiting:

Vomiting (5,750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cevimeline hydrochloride (the active ingredients of Cevimeline) and Cevimeline (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.